Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sandeep Pallerla"'
Autor:
Rushikesh Sable, Nithya Jambunathan, Sitanshu Singh, Sandeep Pallerla, Konstantin G Kousoulas, Seetharama Jois
Publikováno v:
BioTechniques, Vol 65, Iss 3, Pp 149-157 (2018)
Protein–protein interactions (PPI) by homo-, hetero- or oligo-merization in the cellular environment regulate cellular processes. PPI can be inhibited by antibodies, small molecules or peptides, and this inhibition has therapeutic value. A recently
Externí odkaz:
https://doaj.org/article/3ed450dac3884a9993c31e64ffbd547e
Autor:
Seetharama D. Jois, Sitanshu S. Singh, Nithya Jambunathan, Rushikesh Sable, Konstantin G. Kousoulas, Sandeep Pallerla
Publikováno v:
Biotechniques
Protein–protein interactions (PPI) by homo-, hetero- or oligo-merization in the cellular environment regulate cellular processes. PPI can be inhibited by antibodies, small molecules or peptides, and this inhibition has therapeutic value. A recently
Autor:
Sami Nazzal, Sandeep Pallerla, Sara Shakhwar, Rana Darwish, Ahmed Abu Fayyad, Mohammad M. Kamal
Publikováno v:
Pharmaceutical development and technology. 25(4)
Tocosol™ is a tocopherol-based paclitaxel (PTX) nanoemulsion consisting of α-tocopherol (α-T) isomer of vitamin E as a solubilizer and vitamin E TPGS as the primary emulsifier. Despite its positive attributes in early clinical studies, it failed
Autor:
Shanthi Kanthala, Seetharama D. Jois, Sandeep Pallerla, Rushikesh Sable, Yong-Yu Liu, Sitanshu S. Singh
Publikováno v:
Oncotarget
// Shanthi P. Kanthala 1 , Yong-Yu Liu 1 , Sitanshu Singh 1 , Rushikesh Sable 1 , Sandeep Pallerla 1 and Seetharama D. Jois 1 1 Basic Pharmaceutical Sciences, School of Pharmacy, University of Louisiana at Monroe, Monroe LA 71201, USA Correspondence
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 779, p 779 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Breast cancer is one of the leading causes of death in women. With improvements in early-stage diagnosis and targeted therapies, there has been an improvement in the overall survival rate in breast cancer over the past decade. Despite the development
Autor:
Thomas Durek, Seetharama D. Jois, David J. Craik, Ted J. Gauthier, Sandeep Pallerla, Veena Taneja, Rushikesh Sable
Publikováno v:
ACS Chemical Biology. 11:2366-2374
The interaction between the cell-cell adhesion proteins CD2 and CD58 plays a crucial role in lymphocyte recruitment to inflammatory sites, and inhibitors of this interaction have potential as immunomodulatory drugs in autoimmune diseases. Peptides fr
Publikováno v:
Future Oncology. 11:865-878
ABSTRACT Expression of the EGF receptors (EGFRs) is abnormally high in many types of cancer, including 25% of lung cancers. Successful treatments target mutations in the EGFR tyrosine kinase domain with EGFR tyrosine kinase inhibitors (TKIs). However
Autor:
Ted J. Gauthier, Sitanshu S. Singh, Himgauri Naik, Rushikesh Sable, Seetharama D. Jois, Sandeep Pallerla
Publikováno v:
Journal of peptide science : an official publication of the European Peptide Society. 24(2)
HER2 receptors are surface proteins belonging to the epidermal growth factor family of receptors. Their numbers are elevated in breast, lung, and ovarian cancers. HER2-positive cancers are aggressive, have higher mortality rate, and have a poor progn
Publikováno v:
European journal of medicinal chemistry. 125
Doxorubicin (DOX) belongs to the anthracycline class of drugs that are used in the treatment of various cancers. It has limited cystostatic effects in therapeutic doses, but higher doses can cause cardiotoxicity. In the current approach, we conjugate